secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENDRA Life Sciences Inc. (NDRA)
CIK:        0001681682
Form:       8-K
Filed at:   2026-04-21T23:59:59+00:00
Accession:  0001213900-26-045885
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ENDRA receives Nasdaq delisting notice for equity falling below $2.5M minimum
-----------------------------------------------------------------------------

- Nasdaq notified ENDRA on Apr 20, 2026 that stockholders' equity of $2,260,120 as of Dec 31, 2025 fails the $2.5M minimum.
- Company intends to timely request a hearing before Nasdaq Hearings Panel to stay delisting.
- ENDRA previously regained compliance in Nov 2025 but is now non-compliant again after annual report filing.
- No assurance that the company will regain compliance or succeed in appeal; delisting remains possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681682/000121390026045885/0001213900-26-045885-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681682/000121390026045885/ea0287103-8k_endra.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-045885

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer